The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review.
Yimin WangMengxi ShenJinwei ChengXiaodong SunPeter K KaiserPublished in: Journal of ophthalmology (2020)
This systematic review indicates that conbercept may achieve similar BCVA and CRT improvements as ranibizumab and aflibercept, with a superior rate of polyp regression at 12 months.